Admit Tablets 50mg

About Admit Tablets 50mg

Admit Tablets 50mg Uses

• Type 2 diabetes mellitus
• Blood sugar control alongside diet and exercise
• Combination therapy with metformin or other diabetes medicines

Admit Tablets 50mg Benefits

• Lowered blood sugar without major weight gain
• Low risk of hypoglycemia when used alone
• Once-daily dosing supports better adherence
• Effective when combined with metformin for added blood sugar control

What Experts Say

Sitagliptin belongs to the DPP-4 inhibitor class, which works by blocking the enzyme that breaks down incretin hormones in the gut. This allows the body's own incretins to stay active longer, boosting insulin release after meals and reducing glucose production by the liver, all in a glucose-dependent manner.

Because its action depends on blood glucose levels, sitagliptin carries a much lower risk of hypoglycemia than sulfonylureas when used as monotherapy, making it a common second-line choice after metformin. Pakistan carries a very high burden of type 2 diabetes, and DPP-4 inhibitors are frequently prescribed for patients who cannot tolerate sulfonylureas or need additional control beyond metformin alone.

Physicians typically monitor kidney function before starting sitagliptin, since the dose needs adjustment in moderate to severe renal impairment. Patients are also advised to report persistent abdominal pain promptly, as pancreatitis, though rare, is a recognized concern with this drug class, and unexplained joint pain has also been reported in a small number of users.

Drug Class

• DPP-4 Inhibitor (Oral Antidiabetic)

Admit Tablets 50mg formula

• Sitagliptin

Available forms

• Tablet

How to use Admit Tablets 50mg?

• Take one tablet daily, with or without food.
• Swallow the tablet whole with a glass of water.
• Take the tablet at the same time each day for consistent blood sugar control.
• Continue following your prescribed diet and exercise plan alongside this medicine.
• Do not stop taking this medicine without consulting your doctor, even if you feel well.
• Check your blood sugar regularly as advised by your doctor.

Drug Interactions

• Sulfonylureas: Combined use significantly raises the risk of hypoglycemia and may need a dose reduction.
• Insulin: Using together increases low blood sugar risk and requires closer monitoring.
• Digoxin: Sitagliptin can slightly raise digoxin levels, requiring monitoring in patients on this heart medicine.
• ACE Inhibitors: This combination may slightly increase the risk of angioedema.

Risks and warnings

• Pancreatitis Risk: This medicine has been linked to rare cases of severe pancreatitis, presenting as persistent stomach pain.
• Low Blood Sugar: Risk of hypoglycemia increases when combined with insulin or sulfonylureas.
• Kidney Function: Dose adjustment is needed in patients with reduced kidney function.
• Allergic Reactions: Rare but serious skin reactions and swelling of the face or throat have been reported.
• Joint Pain: Some patients experience severe and disabling joint pain that may start any time after beginning treatment.
• Heart Failure History: Caution is needed in patients with a history of heart failure, and any new swelling or breathlessness should be reported.

Admit Tablets 50mg Side Effects

• Headache
• Upper respiratory tract infection symptoms
• Stuffy or runny nose and sore throat
• Nausea
• Diarrhea
• Joint pain
• Skin rash
• Low blood sugar when combined with other diabetes medicines

Storage Conditions

• Store below 30°C in a cool, dry place.
• Keep away from direct sunlight and moisture.
• Keep the tablet in its blister pack until ready to use.
• Keep out of reach of children.